DropGenie is an automation-native digital microfluidics (DMF) platform that miniaturizes and automates complex wet-lab biology, enabling high-throughput, data-rich discovery with 100× fewer cells and minimal human intervention.
What is the problem?
Modern drug discovery is constrained by slow, manual, and high-input wet-lab workflows. Critical steps—gene editing, cell engineering, drug-response assays—require 10⁵–10⁶ cells per condition, expert operators, and complex SOPs.
What is their solution?
DropGenie is an automation-native digital microfluidics (DMF) platform that miniaturizes and automates complex wet-lab biology, enabling high-throughput, data-rich discovery with 100× fewer cells and minimal human intervention. The platform encodes biological workflows in software—rather than SOPs—turning experiments into programmable, closed-loop processes that integrate seamlessly with standard automation systems.
